Video summary

He Analizado +100 Fondos: Debes Conocer Estos 16 (Guía Completa)

Main summary

Key takeaways

Finance

Finance-focused summary (16 “fund gems” to complement portfolios)

Core idea / portfolio role

The presenter argues that many investors already hold “core” global equity index exposure (e.g., S&P 500, MSCI World/ACWI, emerging markets). However, these indexes:

  • are market-cap weighted, concentrating weight in large caps (especially U.S. tech),
  • leave small-cap exposure largely underrepresented,
  • can increase vulnerability to sector concentration.

The video’s goal is to add funds that:

  • improve returns on idle cash/savings (fixed income),
  • diversify away from concentration and/or equity beta,
  • reduce drawdowns in bad markets (especially alternatives),
  • expand diversification where index funds provide limited coverage.

Disclosures / disclaimers

  • The transcript includes a sponsorship disclosure (MyInvestor) and typical marketing language.
  • No explicit “not financial advice” line is visible in the provided subtitles.

Instruments / tickers / funds explicitly mentioned

Equity / index / factor-linked (indexed or systematic)

  • Bang Global Small Cap Index (Bang/Bangward asset manager)
    • Global small caps; replicates MSCI World Small Caps.
  • MyInvestor S&P 500 Equal Weighted Fund
    • Equal-weighted S&P 500.
  • FTSE EPRA Nareit-related “rates/REITs” fund
    • Referred to as a “super-intensive index fund” replicating the index.
  • iShares Developed World Index Class S (BlackRock)
    • Replicates MSCI World
    • Notes: TER 0.06% (MSCI World version), with another class for S&P 500 at 0.05%.
  • Also referenced in methodology/discussion: MSCI World, S&P 500, MSCI ACWI / ACW / ACWi, MSCI World Small Caps, MSCI ACWI IMI.

Alternative / long-short (market-neutral-ish)

  • Jupiter Merian Global Equity Absolute Return (long/short, systematic)
  • Pictet TR Atlas (long/short, discretionary; partial residual market exposure)
  • AQR Style Premia Alternative Fund (multi-asset long/short based on factors)

Active equity (value / quality / compounders / equity income)

  • Robeco BP Global Premium (Boston Partners; value + business momentum)
  • Amundi / “Amund de (defans)” Global Equity (described as Victory Capital Management)
    • Value-quality style; includes emerging markets.
  • Cer Fund / “global compounders” fund
    • Transcript implies a specific concentrated quality-compounders approach, with performance fees and high concentration.
  • Guinness Global Equity Income
    • Quality + dividend growth focus; described as 35 holdings.
  • Example holdings mentioned (names): Microsoft, Alphabet, TSM, Safran, MSCI, ADP (and references such as Samsung Electronics).

Fixed income (cash-like / short duration)

  • Ostrum Credit Ultra Short (referred to as “OSTRO” in comparisons)
  • Tickho Short duration (name partially garbled in subtitles; “Tickho/short”)
  • EBLI Short Corporate Bond (duration around ~2.1)
  • Carmiñac Security / Carmignac Security (duration around ~2.6% stated; higher credit quality mentioned)

Note: Some fund names are partially garbled by auto-subtitles. The transcript provides enough context to identify the categories and comparative metrics.


Key numbers and performance / risk metrics called out

Equity index concentration / allocation

  • U.S. weight in S&P 500 cited as ~60%+ (developed-world context).
  • Example concentration: S&P 500 has ~40% weight in the top 10 technology companies.
  • Equal-weighting mechanics:
    • 500 stocks → 0.2% per stock
    • continuous rebalance to maintain equal weights.

REITs / rates (FTSE EPRA Nareit-style)

  • Cited performance issue:
    • REITs “average rates” annualized return ~8–9%, then ~20% drop since 2022.
  • Explanation:
    • rising rates weakened rate spreads; when spreads adjust, attractiveness may improve.
  • Suggested allocation size:
    • ~5–6% for some investors (not a large allocation overall).

Expense ratio cost race (iShares S share class)

  • BlackRock iShares TER: 0.06% (MSCI World class) vs Fidelity TER: 0.10%.
  • Example compounding over 30 years at 8%:
    • With 0.06% TER: ~€989,600
    • With 0.10% TER: ~€978,000
    • Difference: ~€11,000

Alternative funds: expected return targets and correlations

Jupiter Merian Global Equity Absolute Return

  • As of June 2026:
    • 736 long positions, 554 short positions
    • gross exposure ~200%, net exposure ~-0.8%
  • Return target: ~6–7% annual
  • Correlation example vs Fidelity MSCI (proxy discussed for MSCI World):
    • correlation ~ -0.02% over 5 years (“close to zero”)
  • Drawdown example:
    • MSCI World fell ~20% in April 2025
    • Jupiter fell ~3–4%
  • Positioning note:
    • intended as a diversifier with minimal decline, but “boring” during strong markets.

Pictet TR Atlas

  • Not fully market-neutral; has residual market exposure
  • In the worst 10 months of MSCI World:
    • Pictet fell ~0.6% vs MSCI World ~7.5%
  • Net exposure:
    • “over 18%”
  • Benchmark/strategy reference:
    • Ester mentioned
  • Return examples:
    • around 3–5% generally
    • 2022: about -5%
    • 2018: about -18%
  • Cost caveat:
    • described as “very high cost”.

AQR Style Premia Alternative Fund

  • Upside cited: ~22%, 22%, 15% (recent context)
  • Bad years mentioned: 2018 and 2020 (large drawdowns)
  • Factor drivers:
    • value, momentum, carry, defensive
  • Structure:
    • systematic/quantitative, multi-asset (includes bonds)
  • Risk cautions:
    • high costs
    • “significant volatility”
    • “very bad years” possible
  • Performance comparison note:
    • over 5 years, can outperform MSCI World (per transcript),
    • but since 2018 it hasn’t consistently outperformed; tends to have higher volatility.

Active global equity (valuation / risk / holdings)

Robeco BP Global Premium

  • Portfolio construction:
    • starts with 10,000 companies, narrows to 117
    • tracking error: 8.6%
  • Valuation comparison:
    • P/E: ~12x vs MSCI World ~17.5–20x (transcript says “needs updating” but gives ~20x)
    • Free cash flow yield: ~6.1% vs MSCI World ~4%
  • Tech exposure:
    • ~7% vs MSCI World >60%
  • Regional exposure:
    • U.S. ~42%
  • Expense:
    • around ~1.46% (high for index, typical for active)

Amundi (Victory Capital-style) Global Equity

  • Style:
    • value + quality (high ROIC, earnings and cash growth, strong balance sheet, reasonable valuations)
  • Emerging markets exposure:
    • South Korea ~8.66%, including Samsung Electronics ~2.95%
  • Concentration:
    • ~75 companies
  • Tracking error:
    • ~3–6%
  • Cost caveat:
    • includes performance/success fee (expensive)
  • Net profitability note:
    • cited as outperforming over the last 5 years with smaller drawdowns (excluding costs).

“Cer Fund” / quality compounders (highly concentrated)

  • Described as:
    • “global compounders” in roughly ~30 positions (later transcript: ~28)
    • “Stock Shifter” tool: 65,000 → 500 → further fundamental analysis
  • Risk/return stats cited:
    • annualized return since ~2021 (later context includes ~12% annualized)
    • volatility ~18%
    • Sharpe ~0.83, Sortino ~0.98
    • price-to-benefit ratio ~25x (as presented)
  • Sector concentration:
    • Industrials ~32%
    • Technology ~30%
  • Example top holdings:
    • Microsoft, Safran, Alphabet, TSM, MSCI, ADP

Guinness Global Equity Income

  • Dividend philosophy:
    • sustainable dividend growth (not just high current yield)
  • Dividend yield:
    • described as ~2.6% (garbled figure in subtitles)
  • Holdings:
    • 35 companies, roughly equal weights (each ~3%+)
  • Sector weights:
    • Technology ~20%
    • Defensive spending ~20.60%
    • Healthcare ~14%
  • Guidance:
    • In July 2026, 25 of 35 holdings announced dividend increases for 2026.

Fixed income comparisons (cash alternatives)

General framing

  • Aim: improve on typical savings accounts using short duration/ultra short funds with controlled volatility.

Macro assumptions

  • Savings account rates depend on central bank policy; last change cited as +25 bps (for sponsor product).

Fund-specific comparative outcomes (from transcript comparisons)

  • Returns over 5 years:
    • best annualized return cited as Ostrum, then EBLI, then “Tickho Short”, then Carmiñac Security
  • Volatility:
    • “OSTRO” has hardly any volatility due to very short duration
    • others show more volatility, notably around 2022 due to higher duration during rate hikes
  • Drawdowns (“worst falls”) cited roughly:
    • -1.9%, -1.2%, -0.8%, -0.2%
    • key point: Ostrum/ultra-short fell the least
  • 3-year returns:
    • roughly ~3–4% annualized
  • Presenter takeaway:
    • volatility around ~1% or less and small drawdowns make these potential “idle cash” yield enhancers.

Methodology / framework shared (explicit steps)

1) Addressing “index concentration” and small-cap omission

  • Diagnose overlap using common cores:
    • S&P 500 / MSCI World / ACWI
  • Identify the index construction issue:
    • market-cap weighting → large caps dominate → small caps underweighted
  • Suggested fix:
    • add an indexed global small-cap sleeve to reach desired small-cap exposure
    • example: MSCI World Small Caps replication via Bang Global Small Cap.

2) Handling S&P 500 / MSCI World concentration risk

  • If mega-caps/tech concentration is a concern:
    • use an equal-weighted version of the same index
  • Caution:
    • equal weighting can suppress momentum effects (described as “index survival bias” / winner expansion).

3) Using long/short “alternatives” to reduce market beta

  • Objective:
    • neutralize market risk (“beta”) while harvesting relative performance (“alpha”)
  • Examples:
    • Jupiter (systematic): near-zero net exposure (example net exposure -0.8%)
    • Pictet (discretionary): residual exposure (net exposure over 18%)
    • AQR: systematic factor premia across multi-asset, driven by value/momentum/carry/defensive

4) Fixed-income “cash enhancement” design knobs

Build a savings-like sleeve by choosing combinations of:

  • credit risk (issuer quality; one fund references around triple-B)
  • duration / interest-rate risk (ultra-short vs ~2-year vs ~2.6-year)

Expected trade-off:

  • more credit risk and/or duration may improve returns but can worsen drawdowns in rising-rate periods.

Explicit recommendations / cautions

  • Small-cap gap: if you hold core indexes only, consider adding global small caps for long-term return potential—using controlled weight (not necessarily 20–30%).
  • Concentration worry: consider an equal-weighted S&P 500 sleeve as a partial hedge; avoid treating it as a complete solution for extremely long horizons (the presenter highlights momentum suppression).
  • REITs/rate-spreads cycle: consider a satellite allocation of ~5–6%, not heavy exposure; macro rates matter.
  • Alternatives:
    • use for diversification and drawdown control, not index-like returns
    • factor in high costs.
  • AQR caution: can have “very bad years” and high volatility; don’t overfit to recent 5-year performance.
  • Fixed income: use short/ultra-short duration funds to improve idle cash yield vs savings accounts while controlling volatility and duration risk.

Sponsors / presenters / sources

Presenter

  • Javier (referred to repeatedly as “Javier” / “Javi”).

Sponsor / platform

  • MyInvestor (sponsor)
  • Mentions BlackRock via iShares and bringing iShares “S share class” to Spain (as of September 2025 per transcript).

Asset managers / fund houses referenced

  • BlackRock (iShares)
  • Bang/Bangward
  • Jupiter Merian
  • Pictet
  • AQR
  • Robeco / Boston Partners
  • Amundi (managed by Victory Capital Management in the transcript)
  • Cera / Cer fund (partially garbled name in subtitles)
  • Guinness
  • Ostrum
  • Carmignac
  • (Tickho / “Tickho Short” fund name partially garbled)

Indexes / research sources referenced

  • MSCI, S&P 500, FTSE EPRA Nareit
  • Eugene Fama (“Ujin Fama” in transcript; factor theory context)
  • Mention of AQR based on Fama and factor premia framework.

No additional co-presenters are clearly identified in the provided subtitles.

Rate this summary

Your feedback will help improve summaries.

Improve this summary

Reprocess with a stronger model when the summary feels incomplete or inaccurate.

Pro

Translate summary in another language

Pro

Ask questions to this video

Chat for follow-up questions, clarifications, and source-backed answers.

Coming soon

Share this summary

Original video